Though losing at EBIT level, Hua Medicine (Shanghai) maintai...
Though losing at EBIT level, Hua Medicine (Shanghai) maintains a positive free cash flow. Concern arises from its modest revenue growth and potential risks affecting its stock.
![](https://pubimg-10000538.picsh.myqcloud.com/202205090000028988456dbe14b.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment